Who is sponsoring NCT03123419?

NCT03123419 is sponsored by St. Louis University.

What drugs are being tested in NCT03123419?

Interventions in NCT03123419: Appointment reminders.

What condition does NCT03123419 study?

NCT03123419 studies Vaccine Administration Rates.

Is NCT03123419 still recruiting?

NCT03123419 is currently withdrawn. Last updated 7 March 2018.

Last reviewed 2018-03-07 · How we verify

NCT03123419

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Gardasil Administration

Withdrawn NA Last updated 7 March 2018

What this trial tests

NA trial testing Appointment reminders in Vaccine Administration Rates. Withdrawn.

Timeline

1 February 2018

Primary endpoint
1 March 2019

1 April 2019

Quick facts

Lead sponsor	St. Louis University
Phase	NA
Status	Withdrawn
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Start date	1 February 2018
Primary completion	1 March 2019
Estimated completion	1 April 2019
Sites	1 location across United States

Drugs / interventions tested

Appointment reminders

Conditions studied

Vaccine Administration Rates — all drugs for Vaccine Administration Rates →

Sponsor

St. Louis University

Who can join

Adults 9 to 26, female only, with Vaccine Administration Rates. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of the Gardasil study is to increase the rates of Gardasil vaccination at a maternal fetal Care Center. This will be done by reminding patients via text to come for follow up vaccine appointments.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other St. Louis University trials

Trials by the same sponsor.

NCT07024940 — Short-term Effects of Caffeine and a Multi-ingredient Pre-workout on Exercise Performance · NA · recruiting
NCT06859528 — Step Up to PD: A Community-based Walking Program for People With Parkinson's Disease · NA · recruiting
NCT04158037 — Don't Go There: A Geospatial mHealth App for Gambling Disorder · NA · withdrawn
NCT05406310 — Clinical Outcomes of Persistent Atrial Fibrillation Ablation Using Ablation Index-guided Radiofrequency Catheter Ablatio · withdrawn
NCT05854836 — Preconception Intervention for Incarcerated Women With Substance Use · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03123419 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by St. Louis University
Last refreshed: 7 March 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03123419.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing